Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) stock price, news, charts, stock research, profile.
Open | - |
High | - |
52 Wk High | 27.07 |
AUM | 3.23M |
Dividend | - |
Ex-Div Date | - |
Volume | - |
Market Cap | - |
Mgmt Fee | 0.59% |
P/E Ratio | - |
Prev. Close | $26.94 |
Low | - |
52 Wk Low | 24.92 |
Shares Out | - |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 8.16K |
Beta | - |
Avg. Expense Ratio | 0.59% |
P/B Ratio | - |
You can purchase shares of Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) through any online brokerage.
There are no as such competitors for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
There is no analysis for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
There is no analysis for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF to provide a consensus price target.
The stock price for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) is $26.9396 last updated Today at July 16, 2024 at 8:00 PM EDT.
There are no upcoming dividends for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
Sector | Unknown |
Category | - |
Investment Style | Large Cap Blend |
Fund Inception | May 21, 2024 |
Managers | Anand Desai Ernesto Tong Dustin Lewellyn |
Definition | - |